Donor-dependent, platelets are in short supply. To stop bleeding and repair tissues, they are essential for patients with cancer and those undergoing surgery. Jonathan Thon, PhD, co-founder of Platelet BioGenesis, discusses his organization's work to create platelets that can be used to treat these patients and deliver cancer-fighting drugs.